Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

The report shows a "three-year retrospective analysis of district metrics, offering a holistic view of performance and ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and ...

The examination was two hours long, and exam booklets were provided. The professor was extremely strict and told the class ...

The Board has clarified that no writing will be allowed during the cool-off period, which is meant only for planning answers.

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

IRLAB receives approval for phase Ib study with IRL757 in Parkinson’s disease: Gothenburg, Sweden Friday, December 26, 2025, 17:00 Hrs [IST] Sweden headquartered IRLAB, a compan ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

DAHLONEGA — For the Fall 2025 semester, the University of North Georgia (UNG) awarded more than 1,000 degrees and certificates to graduates. Many of the graduates participated in the fall commencement ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...